PATH | VRL
Menu

WHO Preferred Product Characteristics for Respiratory Syncytial Virus (RSV) Vaccines

This report provides guidance on vaccine development strategies and targets for RSV vaccines. It includes key clinical research and development considerations as well as preferred product characteristics such as indication, target population, safety, and efficacy, for both maternal and pediatric immunization strategies.

Author: World Health Organization

Published: 2017

» Download file (English)

506 KB PDF (Located at apps.who.int)

Resource types: Report

Diseases/vaccines: Respiratory syncytial virus (RSV)

Topics: Vaccine safety and performance, Disease/vaccine specific information

Regions: Global